Nuclear Medicine and Radio Pharmaceuticals Market Report

Global and China Nuclear Medicine and Radio Pharmaceuticals Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 21, 2022
  • PAGES：230
  • REPORT CODE：GMM1481989
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Nuclear Medicine and Radio Pharmaceuticals industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • GE Healthcare

    • Siemens Healthcare

    • Toshiba

    • TriFoil Imaging

    • Biosensors International Group, Ltd

    • Esaote

    • Philips Healthcare

    • Carestream

    • Shimadzu

    • Hitachi

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals

    • Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes

    Application:

    • Diagnostic Applications: SPECT, PET

    • Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Nuclear Medicine and Radio Pharmaceuticals Industry Overview

      • 1.1.1 Nuclear Medicine and Radio Pharmaceuticals Market Scope and Market Segments

      • 1.1.2 Nuclear Medicine and Radio Pharmaceuticals Industry Characteristics

      • 1.1.3 Global and China Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Nuclear Medicine and Radio Pharmaceuticals Production Value and Growth Rate (2017-2028)

    • 1.2 Global Nuclear Medicine and Radio Pharmaceuticals Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals

      • 1.2.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes

    • 1.3 Global Nuclear Medicine and Radio Pharmaceuticals Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Diagnostic Applications: SPECT, PET

      • 1.3.2 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Nuclear Medicine and Radio Pharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Nuclear Medicine and Radio Pharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Nuclear Medicine and Radio Pharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Nuclear Medicine and Radio Pharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Nuclear Medicine and Radio Pharmaceuticals Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Nuclear Medicine and Radio Pharmaceuticals Industry Porter's Five Forces Model Analysis

      • 2.2.3 Nuclear Medicine and Radio Pharmaceuticals Industry PEST Analysis

    • 2.3 Nuclear Medicine and Radio Pharmaceuticals Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Nuclear Medicine and Radio Pharmaceuticals Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Nuclear Medicine and Radio Pharmaceuticals Industry

    Chapter 3 Global and China Nuclear Medicine and Radio Pharmaceuticals Market, by Manufacturer

    • 3.1 Global and China Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Nuclear Medicine and Radio Pharmaceuticals Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Nuclear Medicine and Radio Pharmaceuticals Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Nuclear Medicine and Radio Pharmaceuticals Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Nuclear Medicine and Radio Pharmaceuticals Market Top 3 Players

    Chapter 4 Global and China Nuclear Medicine and Radio Pharmaceuticals Market, by Type (2017-2028)

    • 4.1 Nuclear Medicine and Radio Pharmaceuticals Market Trend, by Type

    • 4.2 Global Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Nuclear Medicine and Radio Pharmaceuticals Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Nuclear Medicine and Radio Pharmaceuticals Price Trend, by Type (2017-2028)

    • 4.3 China Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Nuclear Medicine and Radio Pharmaceuticals Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Nuclear Medicine and Radio Pharmaceuticals Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Nuclear Medicine and Radio Pharmaceuticals Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Nuclear Medicine and Radio Pharmaceuticals Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Nuclear Medicine and Radio Pharmaceuticals Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Nuclear Medicine and Radio Pharmaceuticals Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Nuclear Medicine and Radio Pharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Nuclear Medicine and Radio Pharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Nuclear Medicine and Radio Pharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Nuclear Medicine and Radio Pharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Nuclear Medicine and Radio Pharmaceuticals Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Nuclear Medicine and Radio Pharmaceuticals Market Analysis

    • 7.1 North America Nuclear Medicine and Radio Pharmaceuticals Market, by Type

    • 7.2 North America Nuclear Medicine and Radio Pharmaceuticals Market, by Application

    • 7.3 North America Nuclear Medicine and Radio Pharmaceuticals Market Analysis and Forecast, by Country

      • 7.3.1 United States Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Nuclear Medicine and Radio Pharmaceuticals Market Analysis

    • 8.1 Europe Nuclear Medicine and Radio Pharmaceuticals Market, by Type

    • 8.2 Europe Nuclear Medicine and Radio Pharmaceuticals Market, by Application

    • 8.3 Europe Nuclear Medicine and Radio Pharmaceuticals Market Analysis and Forecast, by Country

      • 8.3.1 Germany Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Nuclear Medicine and Radio Pharmaceuticals Market Analysis

    • 9.1 APAC Nuclear Medicine and Radio Pharmaceuticals Market, by Type

    • 9.2 APAC Nuclear Medicine and Radio Pharmaceuticals Market, by Application

    • 9.3 APAC Nuclear Medicine and Radio Pharmaceuticals Market Analysis and Forecast, by Country

      • 9.3.1 China Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Nuclear Medicine and Radio Pharmaceuticals Market Analysis

    • 10.1 Latin America, Middle East and Africa Nuclear Medicine and Radio Pharmaceuticals Market, by Type

    • 10.2 Latin America, Middle East and Africa Nuclear Medicine and Radio Pharmaceuticals Market, by Application

    • 10.3 Latin America, Middle East and Africa Nuclear Medicine and Radio Pharmaceuticals Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Nuclear Medicine and Radio Pharmaceuticals Company Profiles

      • 11.1 GE Healthcare

        • 11.1.1 GE Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 GE Healthcare Nuclear Medicine and Radio Pharmaceuticals Product Profiles, Application and Specification

        • 11.1.3 GE Healthcare Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Siemens Healthcare

        • 11.2.1 Siemens Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Siemens Healthcare Nuclear Medicine and Radio Pharmaceuticals Product Profiles, Application and Specification

        • 11.2.3 Siemens Healthcare Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Toshiba

        • 11.3.1 Toshiba Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Toshiba Nuclear Medicine and Radio Pharmaceuticals Product Profiles, Application and Specification

        • 11.3.3 Toshiba Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 TriFoil Imaging

        • 11.4.1 TriFoil Imaging Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 TriFoil Imaging Nuclear Medicine and Radio Pharmaceuticals Product Profiles, Application and Specification

        • 11.4.3 TriFoil Imaging Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Biosensors International Group, Ltd

        • 11.5.1 Biosensors International Group, Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Biosensors International Group, Ltd Nuclear Medicine and Radio Pharmaceuticals Product Profiles, Application and Specification

        • 11.5.3 Biosensors International Group, Ltd Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Esaote

        • 11.6.1 Esaote Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Esaote Nuclear Medicine and Radio Pharmaceuticals Product Profiles, Application and Specification

        • 11.6.3 Esaote Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Philips Healthcare

        • 11.7.1 Philips Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Philips Healthcare Nuclear Medicine and Radio Pharmaceuticals Product Profiles, Application and Specification

        • 11.7.3 Philips Healthcare Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Carestream

        • 11.8.1 Carestream Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Carestream Nuclear Medicine and Radio Pharmaceuticals Product Profiles, Application and Specification

        • 11.8.3 Carestream Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Shimadzu

        • 11.9.1 Shimadzu Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Shimadzu Nuclear Medicine and Radio Pharmaceuticals Product Profiles, Application and Specification

        • 11.9.3 Shimadzu Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Hitachi

        • 11.10.1 Hitachi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Hitachi Nuclear Medicine and Radio Pharmaceuticals Product Profiles, Application and Specification

        • 11.10.3 Hitachi Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Nuclear Medicine and Radio Pharmaceuticals Industry Investment Prospect and Risk Assessment

    • 12.1 Nuclear Medicine and Radio Pharmaceuticals Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Nuclear Medicine and Radio Pharmaceuticals Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure China Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Global Nuclear Medicine and Radio Pharmaceuticals Production Value and Growth Rate (2017-2028)

    • Figure China Nuclear Medicine and Radio Pharmaceuticals Production Value and Growth Rate (2017-2028)

    • Figure Global Nuclear Medicine and Radio Pharmaceuticals Market Size and Growth Rate of Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals (2017-2028)

    • Figure Global Nuclear Medicine and Radio Pharmaceuticals Market Size and Growth Rate of Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes (2017-2028)

    • Figure Global Nuclear Medicine and Radio Pharmaceuticals Market Size and Growth Rate of Diagnostic Applications: SPECT, PET (2017-2028)

    • Figure Global Nuclear Medicine and Radio Pharmaceuticals Market Size and Growth Rate of Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications (2017-2028)

    • Figure North America Nuclear Medicine and Radio Pharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Nuclear Medicine and Radio Pharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Nuclear Medicine and Radio Pharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Nuclear Medicine and Radio Pharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Nuclear Medicine and Radio Pharmaceuticals Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Nuclear Medicine and Radio Pharmaceuticals Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Nuclear Medicine and Radio Pharmaceuticals Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Nuclear Medicine and Radio Pharmaceuticals Market Share, by Manufacturer in 2021

    • Figure Global and China Nuclear Medicine and Radio Pharmaceuticals Market Share, by Manufacturer in 2022

    • Table Global Nuclear Medicine and Radio Pharmaceuticals Sales Volume, by Type (2017-2028)

    • Table Global Nuclear Medicine and Radio Pharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure Global Nuclear Medicine and Radio Pharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table Global Nuclear Medicine and Radio Pharmaceuticals Sales Value, by Type (2017-2028)

    • Table Global Nuclear Medicine and Radio Pharmaceuticals Sales Value Share, by Type (2017-2028)

    • Figure Global Nuclear Medicine and Radio Pharmaceuticals Price Trend, by Type (2017-2028)

    • Table China Nuclear Medicine and Radio Pharmaceuticals Sales Volume, by Type (2017-2028)

    • Table China Nuclear Medicine and Radio Pharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure China Nuclear Medicine and Radio Pharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table China Nuclear Medicine and Radio Pharmaceuticals Sales Value, by Type (2017-2028)

    • Table China Nuclear Medicine and Radio Pharmaceuticals Sales Value Share, by Type (2017-2028)

    • Figure China Nuclear Medicine and Radio Pharmaceuticals Price Trend, by Type (2017-2028)

    • Table Global Nuclear Medicine and Radio Pharmaceuticals Sales Volume, by Application (2017-2028)

    • Table Global Nuclear Medicine and Radio Pharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure Global Nuclear Medicine and Radio Pharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Table Global Nuclear Medicine and Radio Pharmaceuticals Sales Value, by Application (2017-2028)

    • Table Global Nuclear Medicine and Radio Pharmaceuticals Sales Value Share, by Application (2017-2028)

    • Figure Global Nuclear Medicine and Radio Pharmaceuticals Sales Value Share, by Application (2017-2028)

    • Table China Nuclear Medicine and Radio Pharmaceuticals Sales Volume, by Application (2017-2028)

    • Table China Nuclear Medicine and Radio Pharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure China Nuclear Medicine and Radio Pharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Table China Nuclear Medicine and Radio Pharmaceuticals Sales Value, by Application (2017-2028)

    • Table China Nuclear Medicine and Radio Pharmaceuticals Sales Value Share, by Application (2017-2028)

    • Figure China Nuclear Medicine and Radio Pharmaceuticals Sales Value Share, by Application (2017-2028)

    • Figure China Nuclear Medicine and Radio Pharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • Figure North America Nuclear Medicine and Radio Pharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Nuclear Medicine and Radio Pharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Nuclear Medicine and Radio Pharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Nuclear Medicine and Radio Pharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • Table North America Nuclear Medicine and Radio Pharmaceuticals Sales Volume, by Type (2017-2028)

    • Table North America Nuclear Medicine and Radio Pharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure North America Nuclear Medicine and Radio Pharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table North America Nuclear Medicine and Radio Pharmaceuticals Sales Volume, by Application (2017-2028)

    • Table North America Nuclear Medicine and Radio Pharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure North America Nuclear Medicine and Radio Pharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure United States Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure United States Nuclear Medicine and Radio Pharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Canada Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Nuclear Medicine and Radio Pharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Nuclear Medicine and Radio Pharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Table Europe Nuclear Medicine and Radio Pharmaceuticals Sales Volume, by Type (2017-2028)

    • Table Europe Nuclear Medicine and Radio Pharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure Europe Nuclear Medicine and Radio Pharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table Europe Nuclear Medicine and Radio Pharmaceuticals Sales Volume, by Application (2017-2028)

    • Table Europe Nuclear Medicine and Radio Pharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure Europe Nuclear Medicine and Radio Pharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure Germany Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Nuclear Medicine and Radio Pharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure UK Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure UK Nuclear Medicine and Radio Pharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure France Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure France Nuclear Medicine and Radio Pharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Italy Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Nuclear Medicine and Radio Pharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Nuclear Medicine and Radio Pharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Spain Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Nuclear Medicine and Radio Pharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Nuclear Medicine and Radio Pharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Poland Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Nuclear Medicine and Radio Pharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Russia Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Nuclear Medicine and Radio Pharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Nuclear Medicine and Radio Pharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Table APAC Nuclear Medicine and Radio Pharmaceuticals Sales Volume, by Type (2017-2028)

    • Table APAC Nuclear Medicine and Radio Pharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure APAC Nuclear Medicine and Radio Pharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table APAC Nuclear Medicine and Radio Pharmaceuticals Sales Volume, by Application (2017-2028)

    • Table APAC Nuclear Medicine and Radio Pharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure APAC Nuclear Medicine and Radio Pharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure China Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure China Nuclear Medicine and Radio Pharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Japan Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Nuclear Medicine and Radio Pharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Nuclear Medicine and Radio Pharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure India Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure India Nuclear Medicine and Radio Pharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Nuclear Medicine and Radio Pharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Nuclear Medicine and Radio Pharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Nuclear Medicine and Radio Pharmaceuticals Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Nuclear Medicine and Radio Pharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Nuclear Medicine and Radio Pharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Nuclear Medicine and Radio Pharmaceuticals Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Nuclear Medicine and Radio Pharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Nuclear Medicine and Radio Pharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Nuclear Medicine and Radio Pharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Nuclear Medicine and Radio Pharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Nuclear Medicine and Radio Pharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Nuclear Medicine and Radio Pharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Nuclear Medicine and Radio Pharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Nuclear Medicine and Radio Pharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Table GE Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GE Healthcare Product Profiles, Application and Specification

    • Table GE Healthcare Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Siemens Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Siemens Healthcare Product Profiles, Application and Specification

    • Table Siemens Healthcare Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Toshiba Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Toshiba Product Profiles, Application and Specification

    • Table Toshiba Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table TriFoil Imaging Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table TriFoil Imaging Product Profiles, Application and Specification

    • Table TriFoil Imaging Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Biosensors International Group, Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Biosensors International Group, Ltd Product Profiles, Application and Specification

    • Table Biosensors International Group, Ltd Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Esaote Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Esaote Product Profiles, Application and Specification

    • Table Esaote Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Philips Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Philips Healthcare Product Profiles, Application and Specification

    • Table Philips Healthcare Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Carestream Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Carestream Product Profiles, Application and Specification

    • Table Carestream Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Shimadzu Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Shimadzu Product Profiles, Application and Specification

    • Table Shimadzu Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Hitachi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Hitachi Product Profiles, Application and Specification

    • Table Hitachi Nuclear Medicine and Radio Pharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US